| The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study CN Bernstein, JF Blanchard, DS Houston, A Wajda Thrombosis and haemostasis 85 (03), 430-434, 2001 | 732 | 2001 |
| A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma JH Verheijen, E Mullaart, GTG Chang, C Kluft, G Wijngaards Thrombosis and Haemostasis 48 (06), 266-269, 1982 | 668 | 1982 |
| Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma JH Verheijen, GTG Chang, C Kluft Thrombosis and haemostasis 51 (03), 392-395, 1984 | 493 | 1984 |
| The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma C Kluft, JH Verheijen, AFH Jie, DC Rijken, FE Preston, HM Sue-Ling, ... Scandinavian journal of clinical and laboratory investigation 45 (7), 605-610, 1985 | 396 | 1985 |
| Molecular mechanisms of initiation of fibrinolysis by fibrin L Medved, W Nieuwenhuizen Thrombosis and haemostasis 89 (03), 409-419, 2003 | 308 | 2003 |
| Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy … JPG Sluijter, WPC Pulskens, AH Schoneveld, E Velema, CF Strijder, ... Stroke 37 (1), 235-239, 2006 | 285 | 2006 |
| Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022 U Kohnert, R Rudolph, JH Verheijen, E Jacoline, D Weening-Verhoeff, ... Protein Engineering, Design and Selection 5 (1), 93-100, 1992 | 238 | 1992 |
| Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1) C Kluft, AFH Jie, DC Rijken, JH Verheijen Thrombosis and haemostasis 59 (02), 329-332, 1988 | 238 | 1988 |
| Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer S Ganesh, CFM Sier, G Griffioen, HJM Vloedgraven, A de Boer, ... Cancer Research 54 (15), 4065-4071, 1994 | 215 | 1994 |
| Involvement of finger domain and kringle 2 domain of tissue‐type plasminogen activator in fibrin binding and stimulation of activity by fibrin. JH Verheijen, MP Caspers, GT Chang, GA De Munk, PH Pouwels, ... The EMBO journal 5 (13), 3525-3530, 1986 | 211 | 1986 |
| Increased gelatinase‐A and gelatinase‐B activities in malignant vs. benign breast tumors R Hanemaaijer, JH Verheijen, TM Maguire, H Visser, K Toet, E McDermott, ... International journal of cancer 86 (2), 204-207, 2000 | 203 | 2000 |
| Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. TJ de Vries, PH Quax, M Denijn, KN Verrijp, JH Verheijen, HW Verspaget, ... The American journal of pathology 144 (1), 70, 1994 | 189 | 1994 |
| Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. PH Quax, GN Van Muijen, EJ Weening-Verhoeff, LR Lund, K Danø, ... The Journal of cell biology 115 (1), 191-199, 1991 | 187 | 1991 |
| Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. PH Quax, CM van den Hoogen, JH Verheijen, T Padro, R Zeheb, ... Journal of Biological Chemistry 265 (26), 15560-15563, 1990 | 185 | 1990 |
| Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig BJGL de Smet, D de Kleijn, R Hanemaaijer, JH Verheijen, L Robertus, ... Circulation 101 (25), 2962-2967, 2000 | 180 | 2000 |
| Understanding Alzheimer disease at the interface between genetics and transcriptomics J Verheijen, K Sleegers Trends in Genetics 34 (6), 434-447, 2018 | 176 | 2018 |
| Cathepsin K is the principal protease in giant cell tumor of bone JHN Lindeman, R Hanemaaijer, A Mulder, PDS Dijkstra, K Szuhai, ... The American journal of pathology 165 (2), 593-600, 2004 | 159 | 2004 |
| A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased … R Hanemaaijer, H Visser, YT Konttinen, P Koolwijk, JH Verheijen Matrix Biology 17 (8-9), 657-665, 1998 | 154 | 1998 |
| Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3 WH Van der Laan, PHA Quax, CA Seemayer, LGM Huisman, ... Gene therapy 10 (3), 234-242, 2003 | 152 | 2003 |
| Plasminogen activation by tissue activator is accelerated in the presence of fibrin (ogen) cyanogen bromide fragment FCB-2 W Nieuwenhuizen, JH Verheijen, A Vermond, GTG Chang Biochimica et Biophysica Acta (BBA)-General Subjects 755 (3), 531-533, 1983 | 144 | 1983 |
Roeland HanemaaijerTNO Metabolic Health ResearchE-mail confirmado em tno.nl
